BDBM221855 3-(6-{[(1r)-1- cyclobutylethyl]amino}- 8-[2-[3-methyl- 1,2,4-oxadiazol-5- yl)piperidin-1-yl]-7- [4- (trifluoromethyl)benzyl]- 7h-purin-2-yl)- 1,2,4-oxadiazol- 5(4h)-one::US9540377, 9.107

SMILES Cc1noc(C2CCCCN2c2nc3nc(-c4noc(=O)[nH]4)nc(N[C@H](C)C4CCC4)c3n2Cc2ccc(C(F)(F)F)cc2)n1

InChI Key InChIKey=CILBZRHONDAZJD-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 221855   

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 221855BDBM221855(US9540377, 9.107 | 3-(6-{[(1r)-1- cyclobutylethyl]...)
Affinity DataIC50: 5.18nMT: 2°CAssay Description:An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2018
Entry Details
US Patent